Drug Manufacturers—General Stocks
| # | Last 7 Days | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2026 |  RAPP Rapport Therapeutics, Inc. - Common Stock | 39.96 USD | +0.60% | -1.09% | +7.10% | +52.58% | 1.91 B USD | ||
| 2067 |  MAZE Maze Therapeutics, Inc. - Common Stock | 31.54 USD | -3.96% | +4.37% | +32.24% | -29.96% | 1.75 B USD | ||
| 2767 |  EIKN Eikon Therapeutics, Inc. - Common Stock | 10.60 USD | -8.62% | -14.79% | +17.00% | -37.83% | 573.87 M USD | ||
| 2958 |  CBIO Crescent Biopharma, Inc. - Common Stock | 16.58 USD | -2.64% | -6.12% | -4.60% | +8.37% | 457.14 M USD | ||
| 3049 |  UPB Upstream Bio, Inc. - Common Stock | 7.58 USD | -3.56% | +7.21% | +16.08% | -31.03% | 412.50 M USD | ||
| 3290 |  AMRN Amarin Corporation plc - American Depositary Shares, each repre | 14.75 USD | -4.59% | -9.34% | +4.09% | -5.21% | 309.29 M USD | ||
| 3552 |  QTTB Q32 Bio Inc. - Common Stock | 12.85 USD | -5.65% | +1.02% | +5.41% | +811.35% | 217.89 M USD | ||
| 3713 |  OKUR OnKure Therapeutics, Inc. - Class A Common Stock | 4.40 USD | +0.46% | -4.97% | -1.12% | +79.59% | 177.74 M USD | ||
| 3724 |  CNTN Canton Strategic Holdings, Inc. - Common Stock | 2.40 USD | -4.00% | -17.81% | -12.73% | -49.47% | 167.53 M USD | ||
| 3925 |  PLYX Polaryx Therapeutics, Inc. - Common Stock | 2.50 USD | -1.19% | -4.21% | +1.63% | -94.44% | 118.36 M USD | ||
| 4043 |  PTHS Pelthos Therapeutics Inc. Common Stock | 25.96 USD | +4.42% | -6.85% | -4.03% | +29.03% | 90.23 M USD | ||
| 4097 |  SCLX Scilex Holding Company - Common Stock | 9.48 USD | -4.53% | +20.30% | +35.43% | +16.61% | 80.50 M USD | ||
| 4202 |  EXOZ eXoZymes Inc. - Common Stock | 7.85 USD | +0.90% | 0.00% | -6.77% | -19.07% | 66.56 M USD | ||
| 4203 |  OSTX OS Therapies Incorporated Common Stock | 1.47 USD | -8.70% | -20.54% | -19.23% | +27.83% | 65.47 M USD | ||
| 4339 |  IBO Impact BioMedical, Inc. Common Stock | 0.46 USD | +2.22% | -2.13% | -14.81% | +4.55% | 49.60 M USD | ||
| 4352 |  DWTX Dogwood Therapeutics, Inc. - Common Stock | 1.39 USD | -3.47% | -11.46% | -7.95% | -53.67% | 46.75 M USD | ||
| 4428 |  MIRA MIRA Pharmaceuticals, Inc. - Common Stock | 0.92 USD | -3.16% | -1.08% | -8.00% | -17.86% | 38.66 M USD | ||
| 4529 |  QCLS Q/C Technologies, Inc. - Common Stock | 3.56 USD | -3.00% | -10.78% | -5.32% | -20.89% | 27.96 M USD | ||
| 4580 |  MDCX Medicus Pharma Ltd. - Common Stock | 0.41 USD | -6.82% | 0.00% | +20.59% | -65.25% | 23.23 M USD | ||
| 4801 |  APUS Apimeds Pharmaceuticals US, Inc. Common Stock | 0.76 USD | +2.70% | -20.00% | -31.53% | -41.98% | 11.47 M USD |
News Drug Manufacturers—General Stocks
BridgeBio Stock Taps Rare Disease Trends and New Diagnosis Growth
Is BBIO Stock a Buy Now or Too Expensive for the Risk Ahead
BridgeBio Stock Outlook Hinges on Attruby & New Drug Catalysts
Eli Lilly Stock (LLY) Gets a Boost as Eczema Treatment Is Approved in Canada - TipRanks.com
AGIO's Filing for Mitapivat in SCD Gets FDA's Priority Tag, Stock Up
Protagonist Therapeutics (PTGX) Surges 7.1%: Is This an Indication of Further Gains?
ZTS Wins European Commission Approval for New Poultry Disease Vaccine
Gainers Drug Manufacturers—General Stocks
 ERNAW Ernexa Therapeutics Inc. - Warrants | 0.1100 | +94.00% |
 MDCXW Medicus Pharma Ltd. - Warrant | 0.7100 | +7.58% |
PTHS Pelthos Therapeutics Inc. Common Stock | 25.96 | +4.42% |
APUS Apimeds Pharmaceuticals US, Inc. Common Stock | 0.76 | +2.70% |
IBO Impact BioMedical, Inc. Common Stock | 0.46 | +2.22% |
 PPCB Propanc Biopharma, Inc. - Common Stock | 1.84 | +1.10% |
 PFE Pfizer, Inc. Common Stock | 24.30 | +0.96% |
EXOZ eXoZymes Inc. - Common Stock | 7.85 | +0.90% |
Losers Drug Manufacturers—General Stocks
 VIVS VivoSim Labs, Inc. - Common Stock | 0.80 | -11.11% |
OSTX OS Therapies Incorporated Common Stock | 1.47 | -8.70% |
EIKN Eikon Therapeutics, Inc. - Common Stock | 10.60 | -8.62% |
 DCOY Decoy Therapeutics Inc. - Common Stock | 6.47 | -7.83% |
MDCX Medicus Pharma Ltd. - Common Stock | 0.41 | -6.82% |
QTTB Q32 Bio Inc. - Common Stock | 12.85 | -5.65% |
AMRN Amarin Corporation plc - American Depositary Shares, each repre | 14.75 | -4.59% |
SCLX Scilex Holding Company - Common Stock | 9.48 | -4.53% |